Biomarkers of neurological status in HIV infection: A 3-year study

Proteomics - Clinical Applications

Volumn 4, Issue 3, 2010, Pages 295-303

  Ragin, Ann B ^a   Wu, Ying ^b   Ochs, Renee ^a   Scheidegger, Rachel ^c   Cohen, Bruce A ^a   Edelman, Robert R ^b   Epstein, Leon G ^d   McArthur, Justin ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain volumetry; Diffusion tensor imaging; Human immunodeficiency virusneurological disease; Monocyte chemoattractant protein 1

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE INHIBITOR; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALGORITHM; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; CLINICAL ARTICLE; DIFFUSION TENSOR IMAGING; DISEASE COURSE; FEMALE; HIGH THROUGHPUT SCREENING; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ATROPHY; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURIES; CHEMOKINES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77951732393     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900083     Document Type: Article

References (62)

1. McArthur, J.C., Brew, B.J., Nath, A., Neurological complications of HIV infection. Lancet Neurol. 2005, 4, 543-555.
2. Antinori, A., Arendt, G., Becker, J.T., Brew, B.J. et al., Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69, 1789-1799.
3. Tozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R. et al., Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J. Neurovirol. 2005, 11, 265-273.
4. Sevigny, J.J., Albert, S.M., McDermott, M.P., McArthur, J.C. et al., Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 2004, 63, 2084-2090.
5. Cherner, M., Cysique, L., Heaton, R.K., Marcotte, T.D. et al., Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J. Neurovirol. 2007, 13, 23-28.
6. Thurnher, M.M., Donovan Post, M.J., Neuroimaging in the brain in HIV-1-infected patients. Neuroimaging Clin. N. Am. 2008, 18, 93-117; viii.
7. Price, R.W., Epstein, L.G., Becker, J.T., Cinque, P. et al., Biomarkers of HIV-1 CNS infection and injury. Neurology 2007, 69, 1781-1788.
8. Smith, S.M., Zhang, Y., Jenkinson, M., Chen, J. et al., Accurate, robust, and automated longitudinal and crosssectional brain change analysis. Neuroimage 2002, 17, 479-489.
9. Smith, S.M., Jenkinson, M., Woolrich, M.W., Beckmann, C.F. et al., Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23, S208-S219.
10. Zhang, Y., Brady, M., Smith, S., Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001, 20, 45-57.
11. Thompson, P., Dutton, R., Hayashi, K., Allen, L. et al., 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage 2006, 31, 12-23.
12. Thompson, P.M., Dutton, R.A., Hayashi, K.M., Toga, A.W. et al., Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD41T lymphocyte decline. Proc. Natl. Acad. Sci. USA 2005, 102, 15647-15652.
13. Basser, P.J., Pierpaoli, C., Microstructural and physiological features of tissues elucidated by quantitative-diffusiontensor MRI. J. Magn. Reson. B 1996, 111, 209-219.
14. Filippi, C.G., Ulug, A.M., Ryan, E., Ferrando, S.J., van Gorp, W., Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. Am. J. Neurodiol. 2001, 22, 277-283.
15. Pomara, N., Crandall, D.T., Choi, S.J., Johnson, G., Lim, K.O., White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res. 2001, 106, 15-24.
16. Ragin, A.B., Storey, P., Cohen, B.A., Edelman, R.R., Epstein, L.G., Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology 2004, 63, 2293-2297.
17. Pfefferbaum, A., Rosenbloom, M.J., Adalsteinsson, E., Sullivan, E.V., Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity: synergistic white matter damage. Brain 2007, 130, 48-64.
18. Thurnher, M.M., Castillo, M., Stadler, A., Rieger, A. et al., Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients. Am. J. Neurodiol. 2005, 26, 2275-2281.
19. Price, R.W., Brew, B.J., The AIDS dementia complex. J. Infect. Dis. 1988, 158, 1079-1083.
20. Sevigny, J.J., Albert, S.M., McDermott, M.P., Schifitto, G. et al., An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch. Neurol. 2007, 64, 97-102.
21. Wachtman, L.M., Skolasky, R.L., Tarwater, P.M., Esposito, D. et al., Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus - associated dementia. Arch. Neurol. 2007, 64, 1264-1272.
22. Le Bihan, D., Looking into the functional architecture of the brain with diffusion MRI. Nat. Rev. 2003, 4, 469-480.
23. Losy, J., Zaremba, J., Monocyte chemoattractant protein-1 is increased in the cerebrospinal fluid of patients with ischemic stroke. Stroke 2001, 32, 2695-2696.
24. Henkel, J.S., Beers, D.R., Siklos, L., Appel, S.H., The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 2006, 31, 427-437.
25. Galimberti, D., Schoonenboom, N., Scarpini, E., Scheltens, P., Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients. Ann. Neurol. 2003, 53, 547-548.
26. Sokolova, A., Hill, M.D., Rahimi, F., Warden, L.A. et al., Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol. 2009, 19, 392-398.
27. Dhillon, N.K., Williams, R., Callen, S., Zien, C. et al., Roles of MCP-1 in development of HIV-dementia. Front. Biosci. 2008, 13, 3913-3918.
28. Zink, M.C., Coleman, G.D., Mankowski, J.L., Adams, R.J. et al., Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. [erratum appears in J. Infect. Dis. 2002 Jun 1;185(11):1696]. J. Infect. Dis. 2001, 184, 1015-1021.
29. Mankowski, J.L., Queen, S.E., Clements, J.E., Zink, M.C., Cerebrospinal fluid markers that predict SIV CNS disease. J. Neuroimmunol. 2004, 157, 66-70.
30. Ragin, A.B., Wu, Y., Storey, P., Cohen, B.A. et al., Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection. Neurology 2006, 66, 1255-1257.
31. Kelder, W., McArthur, J.C., Nance-Sproson, T., McClernon, D., Griffin, D.E., Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 1998, 44, 831-835.
32. Cinque, P., Vago, L., Mengozzi, M., Torri, V. et al., Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS (London, England) 1998, 12, 1327-1332.
33. Avison, M.J., Nath, A., Greene-Avison, R., Schmitt, F.A. et al., Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J. Neurovirol. 2004, 10, 223-232.
34. Avison, M.J., Nath, A., Greene-Avison, R., Schmitt, F.A. et al., Neuroimaging correlates of HIV-associated BBB compromise. J. Neurovirol. 2004, 157, 140-146.
35. Chang, L., Ernst, T., St Hillaire, C., Conant, K., Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir. Ther. 2004, 9, 431-440.
36. Gartner, S., HIV infection and dementia. Science 2000, 287, 602-604.
37. Conant, K., McArthur, J.C., Griffin, D.E., Sjulson, L. et al., Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 1999, 46, 391-398.
38. Weiss, J.M., Nath, A., Major, E.O., Berman, J.W., HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J. Immunol. 1999, 163, 2953-2959.
39. Langford, D., Masliah, E., Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 2001, 11, 306-312.
40. Persidsky, Y., Ghorpade, A., Rasmussen, J., Limoges, J. et al., Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155, 1599-1611.
41. Persidsky, Y., Zheng, J., Miller, D., Gendelman, H.E., Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J. Leukoc. Biol. 2000, 68, 413-422.
42. Sasseville, V.G., Newman, W., Brodie, S.J., Hesterberg, P. et al., Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am. J. Pathol. 1994, 144, 27-40.
43. Glass, J.D., Fedor, H., Wesselingh, S.L., McArthur, J.C., Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 1995, 38, 755-762.
44. Williams, K.C., Hickey, W.F., Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 2002, 25, 537-562.
45. Williams, K., Alvarez, X., Lackner, A.A., Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 2001, 36, 156-164.
46. Ferreira, A.M., Rollins, B.J., Faunce, D.E., Burns, A.L. et al., The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a complex network in acute inflammation. Cytokine 2005, 30, 64-71.
47. Eugenin, E.A., Dyer, G., Calderon, T.M., Berman, J.W., HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS. Glia 2005, 49, 501-510.
48. Lehmann, M.H., Masanetz, S., Kramer, S., Erfle, V., HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. J. Cell Sci. 2006, 119, 4520-4530.
49. Albini, A., Ferrini, S., Benelli, R., Sforzini, S. et al., HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA 1998, 95, 13153-13158.
50. McManus, C.M., Weidenheim, K., Woodman, S.E., Nunez, J. et al., Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am. J. Pathol. 2000, 156, 1441-1453.
51. D'Aversa, T.G., Yu, K.O., Berman, J.W., Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J. Neurovirol. 2004, 10, 86-97.
52. Eldeen, M.B., Deshmane, S.L., Simbiri, K., Khalili, K. et al., MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion. J. Neuroimmunol. 2006, 176, 174-180.
53. Rankine, E.L., Hughes, P.M., Botham, M.S., Perry, V.H., Felton, L.M., Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur. J. Neurosci. 2006, 24, 77-86.
54. Buntinx, M., Hermans, B., Goossens, J., Moechars, D. et al., Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1 H-imidazole-4-carboxyl acidmethyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2. J. Pharmacol. Exp. Ther. 2008, 327, 1-9.
55. Gonzalez, E., Rovin, B.H., Sen, L., Cooke, G. et al., HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. USA 2002, 99, 13795-13800.
56. Stacey, A.R., Norris, P.J., Qin, L., Haygreen, E.A. et al., Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 2009, 83, 3719-3733.
57. Brew, B.J., Lost in translation: again, another failed neuroprotection trial. Neurology 2007, 69, 1308-1309.
58. Eugenin, E.A., D'Aversa, T.G., Lopez, L., Calderon, T.M., Berman, J.W., MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 2003, 85, 1299-1311.
59. Wojna, V., Carlson, K.A., Luo, X., Mayo, R. et al., Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocytederived macrophages: a case study. J. Neurovirol. 2004, 10, 74-81.
60. Berger, J.R., Avison, M., Mootoor, Y., Beach, C., Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations. J. Neurovirol. 2005, 11, 557-562.
61. Laspiur, J.P., Anderson, E.R., Ciborowski, P., Wojna, V. et al., CSF proteomic fingerprints for HIV-associated cognitive impairment. J. Neuroimmunol. 2007, 192, 157-170.
62. Rozek, W., Ricardo-Dukelow, M., Holloway, S., Gendelman, H.E. et al., Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J. Proteome Res. 2007, 6, 4189-4199.